Physician profile
Aaron B Milam
NPI 1104927441
$1,601.27
in general payments reported to CMS, 2019-2025
24 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $255 · 2021: $120 · 2022: $213 · 2023: $132 · 2024: $255 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $249.98 | 2019-2024 | Grafix Pl, Iodosorb Ointment 40g USA, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $230.53 | 2020-2025 | Nuzyra |
| Kerecis Limited | $158.20 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Vertex Pharmaceuticals Incorporated | $126.53 | 2025 | |
| Osiris Therapeutics INC. | $118.42 | 2019 | |
| Biotissue Holdings INC. | $107.82 | 2021-2024 | |
| Musculoskeletal Transplant Foundation INC. | $99.38 | 2020 | |
| Medtronic, INC. | $55.96 | 2022-2025 | Intellis Adaptivestim |
| Bioventus LLC | $47.89 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Misonix INC | $45.08 | 2020-2021 | |
| Bone Support INC. | $42.81 | 2025 | Ceramentbone Void Filler, Cerament G |
| Kci USA, INC. | $40.95 | 2020 | |
| Ani Pharmaceuticals, INC. | $32.49 | 2025 | Purified Cortrophin Gel |
| Access Pro Medical, LLC | $29.63 | 2025 | Matriderm |
| Nabriva Therapeutics, Plc | $29.59 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $27.73 | 2022 | |
| Nevro Corp. | $24.44 | 2022 | |
| Orthofix Medical, INC. | $23.73 | 2019-2023 | Physio-Stim |
| Convatec INC. | $23.53 | 2023 | |
| Abbvie INC. | $22.16 | 2022 | |
| Innovation Technologies INC | $18.15 | 2025 | Irrisept |
| Axogen | $16.98 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Treace Medical Concepts, INC. | $16.56 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $12.73 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Milam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.